BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1405355)

  • 1. Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity.
    Fogo A; Hellings SE; Inagami T; Kon V
    Kidney Int; 1992 Sep; 42(3):770-4. PubMed ID: 1405355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats.
    Kon V; Hunley TE; Fogo A
    Transplantation; 1995 Jul; 60(1):89-95. PubMed ID: 7624949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin A receptor mediates functional but not structural damage in chronic cyclosporine nephrotoxicity.
    Hunley TE; Fogo A; Iwasaki S; Kon V
    J Am Soc Nephrol; 1995 Mar; 5(9):1718-23. PubMed ID: 7780063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction.
    Kivlighn SD; Gabel RA; Siegl PK
    Kidney Int; 1994 Jan; 45(1):131-6. PubMed ID: 8127001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endothelin receptor antagonist, L-754,142 does not prevent cyclosporine A-induced osteopenia in rats.
    Sodam BR; Awumey EM; Sampson WH; Epstein S
    Calcif Tissue Int; 2001 Feb; 68(2):117-21. PubMed ID: 11310347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-participation of thromboxane A2 and leukotriene C4 and D4 in mediating cyclosporine-induced acute renal failure.
    Perico N; Pasini M; Gaspari F; Abbate M; Remuzzi G
    Transplantation; 1991 Nov; 52(5):873-8. PubMed ID: 1835198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lazaroids prevent acute cyclosporine-induced renal vasoconstriction.
    Krysztopik RJ; Bentley FR; Spain DA; Wilson MA; Garrison RN
    Transplantation; 1997 May; 63(9):1215-20. PubMed ID: 9158012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion.
    Ruggenenti P; Perico N; Mosconi L; Gaspari F; Benigni A; Amuchastegui CS; Bruzzi I; Remuzzi G
    Kidney Int; 1993 Mar; 43(3):706-11. PubMed ID: 8455370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effect of a selective endothelin receptor antagonist, BQ-123, on renal function in cyclosporin A-treated rats.
    Tanda K; Seki T; Kobayashi S; Kanagawa K; Chikaraishi T; Togashi M; Nonomura K; Koyanagi T
    Int J Urol; 1994 Dec; 1(4):309-15. PubMed ID: 7614392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for leukotrienes in cyclosporine nephrotoxicity.
    Butterly DW; Spurney RF; Ruiz P; Griffiths R; Albrightson C; Coffman TM
    Kidney Int; 2000 Jun; 57(6):2586-93. PubMed ID: 10844628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1 receptor antagonists protect the kidney against the nephrotoxicity induced by cyclosporine-A in normotensive and hypertensive rats.
    Caires A; Fernandes GS; Leme AM; Castino B; Pessoa EA; Fernandes SM; Fonseca CD; Vattimo MF; Schor N; Borges FT
    Braz J Med Biol Res; 2017 Dec; 51(2):e6373. PubMed ID: 29267497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of silibinin on experimental cyclosporine nephrotoxicity.
    Zima T; Kameníková L; Janebová M; Buchar E; Crkovská J; Tesar V
    Ren Fail; 1998 May; 20(3):471-9. PubMed ID: 9606735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the prostacyclin analogue iloprost on cyclosporin-induced renal hypoperfusion in stable renal transplant recipients.
    Hansen JM; Christensen NJ; Fogh-Andersen N; Strandgaard S
    Nephrol Dial Transplant; 1996 Feb; 11(2):340-6. PubMed ID: 8671790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endothelin in cyclosporine-induced glomerular dysfunction.
    Kon V; Sugiura M; Inagami T; Harvie BR; Ichikawa I; Hoover RL
    Kidney Int; 1990 Jun; 37(6):1487-91. PubMed ID: 2194067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neoral in healthy volunteers.
    Bárány P; Stenvinkel P; Ottosson-Seeberger A; Alvestrand A; Morrow J; Roberts JJ; Salahudeen AK
    Nephrol Dial Transplant; 2001 Mar; 16(3):580-4. PubMed ID: 11239035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction in rats.
    Cavarape A; Endlich K; Feletto F; Parekh N; Bartoli E; Steinhausen M
    Kidney Int; 1998 Apr; 53(4):963-9. PubMed ID: 9551405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A.
    Binet I; Wallnöfer A; Weber C; Jones R; Thiel G
    Kidney Int; 2000 Jan; 57(1):224-31. PubMed ID: 10620203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal hemodynamic effects of L-arginine and sodium nitroprusside in heart transplant recipients.
    Koller-Strametz J; Wolzt M; Fuchs C; Putz D; Wisser W; Mensik C; Eichler HG; Laufer G; Schmetterer L
    Kidney Int; 1999 May; 55(5):1871-7. PubMed ID: 10231449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib offsets the negative renal influences of cyclosporine via modulation of the TGF-β1/IL-2/COX-2/endothelin ET(B) receptor cascade.
    El-Gowelli HM; Helmy MW; Ali RM; El-Mas MM
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):88-95. PubMed ID: 24462674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of verapamil on cyclosporine. A (CsA)-induced nephropathy in ischemic kidney model in rats: changes in systemic hemodynamics and hepatic and renal microsomal cytochrome P-450].
    Kishimoto T; Tsujino T; Nakatani T; Kim T; Ohyama A; Yoshimura R; Sakamoto W; Maekawa T; Kawashima H; Kusunose E
    Hinyokika Kiyo; 1991 Oct; 37(10):1159-64. PubMed ID: 1755405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.